title: Acute effects of troglitazone and nitric oxide on glucose uptake in L929 fibroblast cells.
abstract: The thiazolidinedione class of antidiabetic drugs, including troglitazone, has an insulin-sensitizing effect for patients with type 2 diabetes. However, in some tissues, studies have shown that troglitazone also has an acute insulin-independent effect on glucose uptake. To determine the extent of this acute action of troglitazone, the effect of troglitazone on 2-deoxyglucose (2DG) uptake in L929 fibroblast cells was measured. Troglitazone stimulated 2DG uptake in a dose dependent manner with a maximum stimulation of >300% at 5-10 microM. In addition, nitric oxide has been shown to stimulate glucose uptake in peripheral muscle tissue. Therefore, the effect of nitric oxide on 2DG uptake in L929 cells was also investigated using the nitric oxide donor, sodium nitroprusside (SNP). SNP stimulated 2DG uptake by >200% with a maximally effective concentration of 5 mM. The combined effect of maximally effective concentrations of both stimulants (10 microM troglitazone + 5 mM SNP) was not additive suggesting a shared pathway for 2DG uptake. However, the nitric oxide synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA, 50 microM) had no effect on troglitazone stimulated 2DG uptake, indicating that the troglitazone and nitric oxide pathways converge after nitric oxide production. In addition, 12.5 microM dantrolene was shown to have no effect on either troglitazone or SNP stimulated 2DG uptake suggesting that these stimulatory effects are independent of changes in calcium ion concentrations. These data provide important evidence for the acute regulation of glucose transport through GLUT 1 transporters.
authors.affiliation: Department of Chemistry and Biochemistry, Calvin College, 3201 Burton S.E., Grand Rapids, MI 49546, USA.
authors.forename: David A
authors.initials: DA
authors.lastname: Van Dyke
authors.forename: Lindsey
authors.initials: L
authors.lastname: Walters
authors.forename: Deborah
authors.initials: D
authors.lastname: Frieswyk
authors.forename: Dan
authors.initials: D
authors.lastname: Kokmeyer
authors.forename: Larry L
authors.initials: LL
authors.lastname: Louters
mesh_terms: D000818:Animals; D002839:Chromans / Q000494:pharmacology*; D003847:Deoxyglucose / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D051379:Mice; D009569:Nitric Oxide / Q000502:physiology*; D009599:Nitroprusside / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology*; D045162:Thiazolidinediones; D000077288:Troglitazone; D014407:Tumor Cells, Cultured; D019323:omega-N-Methylarginine / Q000494:pharmacology
chemical_list: D002839:Chromans; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D009599:Nitroprusside; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D003847:Deoxyglucose; D000077288:Troglitazone